BiVACOR wins IDE to start first-in-human study for artificial heart

The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to BiVACOR’s total artificial heart (BTAH), greenlighting the way for an early feasibility study in patients for the first time.